Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

24 Feb 2021

Abstract excerpt

Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcomes and is dependent upon the activity of the transcription factor complex nuclear factor kappa-light-chain-enhancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Long-Term Effects of COVID-19
Share to Stress Responses and Cortisol
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33691249
DOI: 10.1016/j.biopha.2021.111437

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infectionPMID 33691249Read ↗

Fluoxetine as an Anti-Inflammatory Therapy in SARS-CoV-2 InfectionSemantic proximity Read ↗

NSAIDs/Nitazoxanide/Azithromycin Repurposed for COVID-19: Potential Mitigation of the Cytokine Storm Interleukin-6 Amplifier via Immunomodulatory EffectsSemantic proximity Read ↗

Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analysesSemantic proximity Read ↗

Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.Semantic proximity Read ↗

AI Perspectives on the Present and Future of Antidepressant Pharmaceutical Treatment Based on Anti-inflammatory Strategies: A Scoping Review of Randomised Controlled Clinical TrialsSemantic proximity Read ↗

Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of DepressionSemantic proximity Read ↗

Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsSemantic proximity Read ↗

Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathwaysSemantic proximity Read ↗

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2Semantic proximity Read ↗

Revisiting Bupropion Anti-inflammatory Action: Involvement of the TLR2/TLR4 and JAK2/STAT3 Semantic proximity Read ↗

5-HT <sub>2B</sub> serotonin receptor agonist BW723C86 shapes the macrophage gene profile via AhR and impairs monocyte-to-osteoclast differentiationSemantic proximity Read ↗

Revisiting bupropion anti-inflammatory action: involvement of the TLR2/TLR4 and JAK2/STAT3Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.